Viewing Study NCT03524235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:30 PM
Ignite Modification Date: 2026-01-29 @ 11:24 AM
Study NCT ID: NCT03524235
Status: COMPLETED
Last Update Posted: 2024-11-12
First Post: 2018-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
Sponsor: Noah Merin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None CLL View
None Chronic Lymphocytic Leukemia View
None Lymphoma View
None Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/Refractory Lymphoma View
None Multiple Myeloma View
None CLL View
None Bendamustine View
None Haploidentical Stem Cell Transplantation View
None GVHD View
None Allogeneic Stem Cell Transplantation View
None Natural Killer Cell View
None CliniMACS View
None Post-transplantation cyclophosphamide View
None Donor Lymphocyte Infusion View
None Minimal Residual Disease View
None Hodgkin Lymphoma View